Goldman Sachs News

Goldman Sachs CNBC / Oct 29, 2021

“There are certainly a host of challenges that China is facing right now — but we would push back quite vigorously on the sweeping statement that China is ‘uninvestable,’” Moe, chief Asia-Pacific equity strategist and co-head of Asia macro research at the investment banking giant, told CNBC’s “Squawk Box Asia” on Friday.

https://www.cnbc.com/2021/10/25/goldman-sachs-says-china-is-not-uninvestable.html
Open this page

There are pockets of opportunities in China's stock markets despite an increasingly challenging investment backdrop, says Goldman Sachs' Timothy Moe. "There are certainly a host of challenges that China is facing right now - but we would push back quite vigorously on the sweeping statement that China is 'uninvestable,'" Moe, chief Asia-Pacific equity strategist and co-head of Asia macro research at the investment banking giant, told CNBC's "Squawk Box Asia" on Friday.

CNBC

Goldman Sachs Bloomberg / May 2, 2022

Amazon.com (NASDAQ:AMZN)’s stock had its “buy” rating reissued by stock analysts at The Goldman Sachs Group in a report issued on Monday. They currently have a $3,700.00 price objective on the e-commerce giant’s stock. The Goldman Sachs Group’s price objective indicates a potential upside of 51.52%…

https://www.defenseworld.net/2022/05/02/the-goldman-sachs-group-reaffirms-buy-rating-for-amazon-com-nasdaqamzn.html
Open this page

The Goldman Sachs Group Reaffirms Buy Rating for Amazon.com (NASDAQ:AMZN)

Bloomberg

Goldman Sachs Bloomberg / May 2, 2022

SAN ANTONIO, May 2, 2022 /PRNewswire/ -- Clear Channel Outdoor Holdings, Inc., (NYSE:CCO) announced today that Brian Coleman, CFO of Clear Channel Outdoor Holdings, Inc., is scheduled to participate in

https://www.wfmz.com/news/pr_newswire/pr_newswire_stocks/clear-channel-outdoor-holdings-inc-to-participate-in-the-goldman-sachs-leveraged-finance-2022-conference/article_701bef8e-e22b-53b9-8787-c35088f09280.html
Open this page

Clear Channel Outdoor Holdings, Inc. To Participate In The Goldman Sachs Leveraged Finance 2022 Conference

Bloomberg

Goldman Sachs Bloomberg / May 2, 2022

Goldman Sachs BDC (NYSE:GSBD – Get Rating) and Tekla Healthcare Investors (NYSE:HQH – Get Rating) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, risk, dividends, analyst recommendations…

https://www.defenseworld.net/2022/05/02/goldman-sachs-bdc-nysegsbd-versus-tekla-healthcare-investors-nysehqh-financial-survey.html
Open this page

Goldman Sachs BDC (NYSE:GSBD) versus Tekla Healthcare Investors (NYSE:HQH) Financial Survey

Bloomberg

Goldman Sachs Bloomberg / May 2, 2022

KKR & Co. Inc. (NYSE:KKR – Get Rating) was downgraded by equities researchers at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a report released on Sunday, The Fly reports. Other research analysts also recently issued research reports about the company. Oppenheimer raised thei…

https://www.defenseworld.net/2022/05/01/kkr-co-inc-nysekkr-downgraded-by-the-goldman-sachs-group-to-neutral.html
Open this page

KKR & Co. Inc. (NYSE:KKR) Downgraded by The Goldman Sachs Group to Neutral

Bloomberg

Goldman Sachs Bloomberg / May 2, 2022

Equities researchers at The Goldman Sachs Group started coverage on shares of 2seventy bio (NASDAQ:TSVT – Get Rating) in a report issued on Monday, The Fly reports. The firm set a “buy” rating on the stock. Other research analysts have also issued research reports about the stock. Cowen assumed cove…

https://www.defenseworld.net/2022/05/02/2seventy-bio-nasdaqtsvt-coverage-initiated-by-analysts-at-the-goldman-sachs-group.html
Open this page

2seventy bio (NASDAQ:TSVT) Coverage Initiated by Analysts at The Goldman Sachs Group

Bloomberg

Goldman Sachs Defense World / May 1, 2022

Equities analysts predict that The Goldman Sachs Group, Inc. (NYSE:GS – Get Rating) will announce earnings of $8.65 per share for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for The Goldman Sachs Group’s earnings, with the highest EPS estimate comi…

https://www.defenseworld.net/2022/05/01/brokerages-expect-the-goldman-sachs-group-inc-nysegs-to-announce-8-65-eps.html
Open this page

Brokerages Expect The Goldman Sachs Group, Inc. (NYSE:GS) to Announce $8.65 EPS

Defense World

Goldman Sachs StreetInsider.com / Apr 30, 2022

The Goldman Sachs Group set a GBX 6,950 ($88.58) price target on AstraZeneca (LON:AZN – Get Rating) in a research note published on Friday morning, Borsen Zeitung reports. AZN has been the subject of a number of other reports. Barclays reissued an overweight rating and set a £115 ($146.57) price obj…

https://www.defenseworld.net/2022/04/30/the-goldman-sachs-group-reiterates-gbx-6950-price-target-for-astrazeneca-lonazn.html
Open this page

The Goldman Sachs Group Reiterates “GBX 6950” Price Target for AstraZeneca (LON:AZN)

StreetInsider.com

Prev 01 02 03 04 05 Next